ibrutinib,venetoclax
Roche,Abbvie,Janssen
['ibru', 'cll']
our pi eric eldering presents at #eha2023 the last results of the group on a new effect of ibrutinib on cll cells, which contributes to their increased sensitivity to ven in combination treatment. check out the paper just published in ! 
News from the Immuno-Hematology group @AmsterdamUMC, researching Chronic Lymphocytic Leukemia. PI's: profs A Kater & E Eldering. Tweets by group members